The filing

Reappointment of Managing Director

Company

GlaxoSmithKline Pharmaceuticals Ltd · BSE 500660

Filed

3 August 2026, 16:14 IST

BSE category

Company Update / Change in Management

Tag

Change in Management · selected

Source

Open the filing on BSE →

Why it led

• First Change in Management from this company — not seen in the 98 trading days on record
• Mid cap · NIFTY 500
• 6 filings today

Selected by the ranker from 44 filings that day. Each line above is a component of that score, not a comment on the filing.

How often this tag appears

2,682 of 90,303 filings in the published window carry Change in Management · 2.97%

Around it

Also filed by GlaxoSmithKline Pharmaceuticals Ltd on 3 August 2026

• Analyst / Investor Meet - Outcome Analyst / Investor Meet20:44 IST
• Resignation of Director Resignation16:12 IST
• Change in Directorate Change in Directorate16:11 IST
• Press Release / Media Release Press Release16:10 IST
• Analyst / Investor Meet - Outcome Analyst / Investor Meet16:00 IST
• Results For Quarter 30Th June 2026 Results15:48 IST

Most recent filings from GlaxoSmithKline Pharmaceuticals Ltd

• Board Meeting Intimation for To Consider, Approve And Take On Record The Un-Audited Financial Results For The Second Quarter & Half Year Ended 30Th September 2026. Board Meeting13 October 2026 · 16:03 IST
• Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 Compliance Certificate12 October 2026 · 16:29 IST
• Closure of Trading Window Trading Window25 September 2026 · 14:35 IST